Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Most research on neurodegenerative diseases has focused on neurons, yet glia help form and maintain the synapses whose loss is so prominent in these conditions. To investigate the contributions of glia to Huntington's disease (HD), we profiled the gene expression alterations of Drosophila expressing human mutant Huntingtin (m HTT ) in either glia or neurons and compared these changes to what is observed in HD human and HD mice striata. A large portion of conserved genes are concordantly dysregulated across the three species; we tested these genes in a high-throughput behavioral assay and found that downregulation of genes involved in synapse assembly mitigated pathogenesis and behavioral deficits. To our surprise, reducing d NRXN3 function in glia was sufficient to improve the phenotype of flies expressing m HTT in neurons, suggesting that mHTT's toxic effects in glia ramify throughout the brain. This supports a model in which dampening synaptic function is protective because it attenuates the excitotoxicity that characterizes HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Maps of random walks on complex networks reveal community structure
Rosvall, M., & Bergstrom, C. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706851105 · Cited by 4,583
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 1×
“Modifiers of mHTT-induced pathogenesis identified in our study, such as metabotropic glutamate receptors and the scaffold protein HOMER1, regulate calcium and glutamate signaling in astrocytes (Buscemi et al., 2017; Spampinato et al., 2018).”
BackgroundMutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851 · cited 3×
“We speculate that the consequences of loss of function of these genes depend on both dosage and context: modest reductions of gene expression can be protective in the context of HD pathogenesis, whereas a more severe loss of function results in ASD and OCD.”
BackgroundNeuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 6×
“Four subgraphs of STRING were then induced on each core gene set separately.”
MethodInfluentialA survey of human brain transcriptome diversity at the single cell level
Darmanis, S., Sloan, S. A., Zhang, Y., Enge, M., Caneda, C., Shuer, L. M., Hayden Gephart, M. G., Barres, B. A., & Quake, S. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507125112 · Cited by 1,401
Regional and cellular gene expression changes in human Huntington's disease brain
Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl013 · Cited by 804
Targeting Huntingtin Expression in Patients with Huntington’s Disease
Tabrizi, S. J., Leavitt, B. R., Landwehrmeyer, G. B., Wild, E. J., Saft, C., Barker, R. A., Blair, N. F., Craufurd, D., Priller, J., Rickards, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900907 · Cited by 708
Lian, H., Yang, L., Cole, A., Sun, L., Chiang, A. C.-A., Fowler, S. W., Shim, D. J., Rodriguez-Rivera, J., Taglialatela, G., Jankowsky, J. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.018 · Cited by 697
Filipello, F., Morini, R., Corradini, I., Zerbi, V., Canzi, A., Michalski, B., Erreni, M., Markicevic, M., Starvaggi-Cucuzza, C., Otero, K., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.016 · Cited by 695
Identification of genes that modify ataxin-1-induced neurodegeneration
Fernandez-Funez, P., Nino-Rosales, M. L., de Gouyon, B., She, W.-C., Luchak, J. M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P. J., et al. (2000) · Nature · doi:10.1038/35040584 · Cited by 661
Self-citationTong, X., Ao, Y., Faas, G. C., Nwaobi, S. E., Xu, J., Haustein, M. D., Anderson, M. A., Mody, I., Olsen, M. L., Sofroniew, M. V., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3691 · Cited by 592
Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds
Li, Z., Wang, C., Wang, Z., Zhu, C., Li, J., Sha, T., Ma, L., Gao, C., Yang, Y., Sun, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1722-1 · Cited by 551 · cited 1×
“We were particularly interested to discover whether any such shared modifiers exert their effect by reducing mHTT levels, which is considered a promising approach to therapy (Al-Ramahi et al., 2018; Barker et al., 2020; Caron et al., 2020; Li et al., 2019; Tabrizi et al., 2019; Wang et al., 2014; Wood et al., 2018; Ya…”
BackgroundSelf-citationLitvinchuk, A., Wan, Y.-W., Swartzlander, D. B., Chen, F., Cole, A., Propson, N. E., Wang, Q., Zhang, B., Liu, Z., & Zheng, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.031 · Cited by 523
Self-citationAstrocytic neuroligins control astrocyte morphogenesis and synaptogenesis
Stogsdill, J. A., Ramirez, J., Liu, D., Kim, Y. H., Baldwin, K. T., Enustun, E., Ejikeme, T., Ji, R.-R., & Eroglu, C. (2017) · Nature · doi:10.1038/nature24638 · Cited by 506 · cited 1×
“…and LRRTM1 have been associated with various disorders of synaptic dysfunction, including autism spectrum disorder (ASD), schizophrenia, and obsessive compulsive disorder (OCD) (Nakanishi et al., 2017; Jamain et al., 2003; Südhof, 2008; Vaags et al., 2012; Wang et al., 2018; Windrem et al., 2017).”
BackgroundBayraktar, O. A., Bartels, T., Holmqvist, S., Kleshchevnikov, V., Martirosyan, A., Polioudakis, D., Ben Haim, L., Young, A. M. H., Batiuk, M. Y., Prakash, K., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0602-1 · Cited by 489
Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice
Langfelder, P., Cantle, J. P., Chatzopoulou, D., Wang, N., Gao, F., Al-Ramahi, I., Lu, X.-H., Ramos, E. M., El-Zein, K., Zhao, Y., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4256 · Cited by 385 · cited 2×
“We did not take the magnitude of fold-change into account, only the direction (upregulated or downregulated) (Langfelder et al., 2016).”
BackgroundMethodSelf-citationHuntington’s disease alters human neurodevelopment
Barnat, M., Capizzi, M., Aparicio, E., Boluda, S., Wennagel, D., Kacher, R., Kassem, R., Lenoir, S., Agasse, F., Braz, B. Y., et al. (2020) · Science · doi:10.1126/science.aax3338 · Cited by 326
Drosophila Central Nervous System Glia
Freeman, M. R. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020552 · Cited by 309 · cited 1×
“DOI: https://doi.org/10.7554/eLife.64564 12 of 30 microglia including phagocytosis (Chung et al., 2020; Freeman, 2015; Freeman and Doherty, 2006; Ziegenfuss et al., 2012).”
BackgroundInfluentialPotential function for the Huntingtin protein as a scaffold for selective autophagy
Ochaba, J., Lukacsovich, T., Csikos, G., Zheng, S., Margulis, J., Salazar, L., Mao, K., Lau, A. L., Yeung, S. Y., Humbert, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420103111 · Cited by 308 · cited 1×
“, 2012) and are a tractable model system for studying HD and other neurodegenerative diseases (Al-Ramahi et al., 2018; Bondar et al., 2018; Donnelly et al., 2020; Fernandez-Funez et al., 2000; Filimonenko et al., 2010; Goodman et al., 2019; Ochaba et al., 2014; Olsen and Feany, 2019; O’Rourke et al., 2013; Rousseaux e…”
BackgroundSingle-nucleus RNA-seq identifies Huntington disease astrocyte states
Al-Dalahmah, O., Sosunov, A. A., Shaik, A., Ofori, K., Liu, Y., Vonsattel, J. P., Adorjan, I., Menon, V., & Goldman, J. E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0880-6 · Cited by 264
Astrocyte molecular signatures in Huntington’s disease
Diaz-Castro, B., Gangwani, M. R., Yu, X., Coppola, G., & Khakh, B. S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8546 · Cited by 255 · cited 2×
“from HD patients and mouse models of HD (Al-Dalahmah et al., 2020; Diaz-Castro et al., 2019) developed molecular profiles that distinguish HD-affected astrocytes from astrocytes found in healthy brain tissue, but the physiological consequences of the gene expression changes were unclear.”
BackgroundInfluentialSynaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
McInnes, J., Wierda, K., Snellinx, A., Bounti, L., Wang, Y.-C., Stancu, I.-C., Apóstolo, N., Gevaert, K., Dewachter, I., Spires-Jones, T. L., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.022 · Cited by 242 · cited 1×
“Synaptic dysfunction is a common theme among many neurodegenerative disorders (McInnes et al., 2018; Phan et al., 2017; Prots et al., 2018).”
BackgroundJiang, R., Diaz-Castro, B., Looger, L. L., & Khakh, B. S. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3693-15.2016 · Cited by 237 · cited 1×
“Astrocytic mHTT expression may contribute to neuronal excitotoxicity by elevating levels of glutamate, potassium, and calcium at the synapse (Garcia et al., 2019; Jiang et al., 2016; Tong et al., 2014).”
BackgroundHuman glia can both induce and rescue aspects of disease phenotype in Huntington disease
Benraiss, A., Wang, S., Herrlinger, S., Li, X., Chandler-Militello, D., Mauceri, J., Burm, H. B., Toner, M., Osipovitch, M., Jim Xu, Q., et al. (2016) · Nature Communications · doi:10.1038/ncomms11758 · Cited by 199
Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain
Pearce, M. M. P., Spartz, E. J., Hong, W., Luo, L., & Kopito, R. R. (2015) · Nature Communications · doi:10.1038/ncomms7768 · Cited by 159 · cited 1×
“…as a target for treating HD. Interestingly, SERPINA1 expression is low in the healthy brain but it is upregulated in several disease conditions, consistent with a potential role in neuroinflammation (Abu-Rumeileh et al., 2020; Cabezas-Llobet et al., 2018; Gollin et al., 1992; Peng et al., 2015).”
BackgroundLoss-or gain-of-function mutations in ACOX1 cause axonal loss via different mechanisms
Chung, H.-L., Wangler, M. F., Marcogliese, P. C., Jo, J., Ravenscroft, T. A., Zuo, Z., Duraine, L., Sadeghzadeh, S., Li-Kroeger, D., Schmidt, R. E., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.02.021 · Cited by 154
Osipovitch, M., Asenjo Martinez, A., Mariani, J. N., Cornwell, A., Dhaliwal, S., Zou, L., Chandler-Militello, D., Wang, S., Li, X., Benraiss, S.-J., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.010 · Cited by 120
Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
Spampinato, S. F., Copani, A., Nicoletti, F., Sortino, M. A., & Caraci, F. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00414 · Cited by 105 · cited 1×
“We introduced a heat-shock-induced lethality mutation on the Y chromosome (YP{hs-hid}) to the disease and cell-specific driver stocks to increase the efficiency of virgin collection (Starz-Gaiano et al., 2001).”
MethodMutant Huntingtin Is Secreted via a Late Endosomal/Lysosomal Unconventional Secretory Pathway
Trajkovic, K., Jeong, H., & Krainc, D. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0118-17.2017 · Cited by 85
Rousseaux, M. W. C., Vázquez-Vélez, G. E., Al-Ramahi, I., Jeong, H.-H., Bajić, A., Revelli, J.-P., Ye, H., Phan, E. T., Deger, J. M., Perez, A. M., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0254-18.2018 · Cited by 61 · cited 1×
“…and N-terminal (HTTNT231Q128) models were used in this set of experiments since both the full protein and N-terminal HD fragments accumulate in the human brain as a result of proteolysis and mis-splicing (Kim et al., 2001; Neueder et al., 2017; Sathasivam et al., 2013; Wellington et al., 2002).”
MethodSelf-citationMiller, J. A., Menon, V., Goldy, J., Kaykas, A., Lee, C.-K., Smith, K. A., Shen, E. H., Phillips, J. W., Lein, E. S., & Hawrylycz, M. J. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-154 · Cited by 48
Cited by
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
Brandebura, A. N., Paumier, A., Onur, T. S., & Allen, N. J. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-022-00641-1 · Cited by 427
Self-citationApplication of Novel Degraders Employing Autophagy for Expediting Medicinal Research
Li, X., Liu, Q., Xie, X., Peng, C., Pang, Q., Liu, B., & Han, B. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01712 · Cited by 46
Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures
(2025) · doi:10.1038/s44320-025-00096-3 · Cited by 7
Manor, J., Jangam, S. V., Chung, H.-L., Bhagwat, P., Andrews, J., Chester, H., Kondo, S., Srivastav, S., Botas, J., Moser, A. B., et al. (2024) · doi:10.1101/2024.09.23.614586 · Cited by 2
Self-citation
Metadata
- Authors
- Onur, T. S., Laitman, A., Zhao, H., Keyho, R., Kim, H., Wang, J., Mair, M., Wang, H., Li, L., Perez, A., de Haro, M., Wan, Y.-W., Allen, G., Lu, B., Al-Ramahi, I., Liu, Z., & Botas, J.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-04-19
- Volume
- 10
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W3156995404
- Cited by
- 52
- References
- 33
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.